Zura Bio Ltd.

06/14/2024 | Press release | Distributed by Public on 06/14/2024 03:56

Phase 1 Clinical Trial Evaluating the Pharmacokinetics and Pharmacodynamics of a Novel IL-17A and BAFF Dual Antagonist in Sjogren’s Syndrome